NUFYMCO
Live / Allowed — Approved for publication (as of 06 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99736342
- Mark type
- Word mark
- Filed
- 31 Mar 2026
- Attorney of record
- Samantha N. Skains-Menchaca
Goods and services
- Class 005 — Pharmaceuticals: Medicines and pharmaceutical preparations for human medical use, other than for dermatological purposes, in particular ophthalmological preparations for the treatment of eye diseases and ailments
Owner
- Bioeq AG, Zug, CH
Prosecution history
- 06 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Oct 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Oct 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Sept 2026 — ASSIGNED TO LIE
- 28 Sept 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 01 Sept 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 01 Sept 2026 — LETTER OF SUSPENSION E-MAILED
- 01 Sept 2026 — SUSPENSION LETTER WRITTEN
- 01 Sept 2026 — USE AMENDMENT ACCEPTED
- 25 Aug 2026 — AMENDMENT TO USE PROCESSING COMPLETE
- 25 Aug 2026 — USE AMENDMENT FILED
- 25 Aug 2026 — TEAS AMENDMENT OF USE RECEIVED
- 13 Jul 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 13 Jul 2026 — LETTER OF SUSPENSION E-MAILED
- 13 Jul 2026 — SUSPENSION LETTER WRITTEN